Pressure BioSciences Wins $1.5 Million Contract From CBD Supply MD To Bring A Potent Nano-CBD Topical Spray To Store Shelves In April

This week, Pressure BioSciences, Inc. PBIO (“PBIO”) announced that it had received a $1.5 million contract for its breakthrough CBD nanoemulsion products. The manufacturing and distribution contract is with CBD Supply MD, the first CBD store in Maryland and one of the largest in the mid-Atlantic region. The leading retailer will begin selling PBIO’s nano-CBD topical spray in their stores as well as online starting in April. PBIO estimates as much as $250,000 of that $1.5 million in revenue will be generated in the upcoming second quarter alone. 

PBIO’s Topical CBD Nanoemulsion Spray Is A “Game Changer” Offering Consumers More Potent Pain Relief

“Their best-in-class UltraShear processed nano-CBD manifests unmatched bioavailability and long-term shelf stability that is unparalleled in the industry,” said Mr. Keith E. Manley, Co-founder of CBD Supply MD in a statement about the new deal, adding that the topical spray was the first of many nano emulsified products the retailer plans to bring to market in partnership with PBIO.

The 30-milliliter bottle contains 40 milligrams of CBD oil per milliliter. But what makes the product such a game changer in the industry is that it’s manufactured using PBIO’s patented UltraShear™ technology. The pressure-based platform is uniquely designed to break down oil molecules using pressure rather than heat or chemicals that could alter or damage the product. More importantly, it breaks those molecules down into nano-sized droplets so small that they won’t recombine into larger droplets after the emulsion settles. 

This nanoemulsion process creates a more shelf-stable product that’s also more easily absorbed by the body. Oil-based nutrients and supplements, like CBD, are typically poorly absorbed by the body, with as little as 6% of the dose listed on the bottle actually making it into the bloodstream. Topical treatments can have even lower absorption rates because the large oil molecules struggle to penetrate all the way through the skin barrier. By emulsifying CBD into nano-sized droplets, the oil effectively becomes water-soluble and, as a result, more easily absorbed. 

Studies have shown that CBD can decrease neuropathic pain, reduce inflammation, and potentially even alleviate psoriasis, eczema and other inflammatory skin conditions. Demand for topical CBD products, in particular, is growing as it’s a way to get targeted pain relief and soothe inflammation where it’s needed rather than taking an oral dose and waiting for it to be absorbed and eventually spread to the site of your pain. 

Whether it’s athletes wanting to soothe sore muscles after training or people suffering from chronic pain conditions like arthritis or back pain, topical CBD treatments offer a less addictive, less side-effect-heavy alternative to opioids and other commonly prescribed painkillers. 

For consumers, the better absorption potential of PBIO’s topical CBD spray means they can potentially get more relief with less product, stretching a single bottle longer than a less potent alternative. By offering a more bioavailable nanoemulsion, PBIO can increase potency without having to just increase the CBD concentration, making it a more cost-effective process.

An initial shipment of 850 vials of PBIO’s breakthrough CBD nanoemulsion spray is already underway with a target of reaching CBD Supply MD shelves by mid-April. 

The announcement comes on the heels of a slew of exciting news from the pressure-based technology company, including the news that PBIO’s largest shareholder exchanged over $10 million of debt, or more than half of PBIO’s total outstanding debt, into equity at $2.50 per share. And, in January, PBIO announced a new partnership with One World Products OWPC to develop a CBD-infused sports drink using the same nanoemulsion technology. All of this helps PBIO further toward its goal of uplisting to NASDAQ or NYSE before the end of the year. 

Featured photo by Alesia Kozik on Pexels

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.